HPRL Awarded Phase I Small Business Innovation Research (SBIR) Grant for “Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous Leukemia (CML).”
Awarded SBIR Phase II Grant
HPRL Awarded Phase II Small Business Innovation Research (SBIR) Grant for the “Discovery and Development of Anti-Diabetic Drugs.”
JDRF Partners with HPRL
The Juvenile Diabetes Research Foundation (JDRF) Partners with HPRL for therapeutic discovery and development in the area of Type I Diabetes.
